A Study to Assess NEU-111 in Healthy Participants

NCT06500442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NEU-111
DRUG: Placebo

Sponsor

Neuron23 Inc.